The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest insulin pens, syringes, pumps, and injectors market share.

The global insulin pens, syringes, pumps, and injectors market is expected to grow from $21.09 billion in 2022 to $22.81 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The insulin pens, syringes, pumps and injectors market size is expected to grow to $29.75 billion in 2027 at a CAGR of 6.9%.

Major Driver In The Insulin Pens, Syringes, Pumps And Injectors Market ­– Increase In The Prevalence Of Diabetes Globally
Diabetes affected around 34.2 million individuals in the United States in 2020, according to the Centres for Disease Control and Prevention (CDC). According to the International Diabetes Federation, roughly 537 million adults worldwide will have diabetes in 2021, rising to 783 million by 2045, fueling the demand for insulin pens, syringes, pumps, and injectors.

View More On The Insulin Pens, Syringes, Pumps And Injectors Market Report 2023 – https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Key Insulin Pens, Syringes, Pumps And Injectors Market Segments
1) By Type: Pens, Injectors And Pumps, Syringes
2) By End Users: Hospitals, Homecare, Other End Users
3) By Pens: Reusable, Disposable
4) By Pumps: Tubed Pumps, Tubeless Pumps

Recent Insulin Pens, Syringes, Pumps And Injectors Market Trend – Technological Advancement
Many firms are concentrating on technology developments in insulin delivery systems in order to provide insulin in an effective and safe manner. For example, the FDA approved the use of Omnipod 5 for children over the age of two with type 1 diabetes in September 2022. Omnipod is the first tubeless automated insulin delivery system designed specifically for persons with type 1 diabetes.

Insulin Pens, Syringes, Pumps And Injectors Market Prominent Players
Major players in the insulin pens, syringes, pumps, and injectors market are Novo Nordisk A/S, Eli Lilly and Company, Medtronic PLC., Abbott, Insulet Corporation, Sanofi, Roche F. Hoffmann-La Roche Ltd., Becton, Animas Corporation, and Ypsomed Holding AG.

Request A Sample Of The Global Insulin Pens, Syringes, Pumps And Injectors Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp

The Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2023  provides a comprehensive overview on the insulin pens, syringes, pumps, and injectors market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the insulin pens, syringes, pumps, and injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Insulin pens, syringes, pumps, and injectors are used to manage blood glucose levels in diabetic patients. These are reusable or disposable equipment used to inject a diabetic patient’s blood with the desired dose of insulin.

View More Related Reports –
Insulin Patch Pumps Global Market Report 2023
Insulin Drugs Global Market Report 2023
Wearable Injectors Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model